Anti-Topoisomerase II alpha 抗体 [EP1102Y] (ab52934)

ab52934 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab52934 は 5 報の論文で使用されています。

  • Dykhuizen EC  et al. BAF complexes facilitate decatenation of DNA by topoisomerase IIa. Nature 497:624-7 (2013). IP ; Mouse, Human . PubMed: 23698369
  • Taniai E  et al. Ochratoxin A induces karyomegaly and cell cycle aberrations in renal tubular cells without relation to induction of oxidative stress responses in rats. Toxicol Lett 224:64-72 (2013). Rat . PubMed: 24120684
  • Kimura M  et al. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model. Exp Toxicol Pathol 65:979-88 (2013). Rat . PubMed: 23474136
  • Park JS  et al. Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2K(b)-restricted T cell epitope. Cancer Immunol Immunother 59:747-57 (2010). PubMed: 19936747
  • Adler M  et al. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 30:711-9 (2009). PubMed: 19237604

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"